<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">uzspbgmu</journal-id><journal-title-group><journal-title xml:lang="ru">Учёные записки Первого Санкт-Петербургского государственного медицинского университета имени академика И. П. Павлова</journal-title><trans-title-group xml:lang="en"><trans-title>The Scientific Notes of the Pavlov University</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1607-4181</issn><issn pub-type="epub">2541-8807</issn><publisher><publisher-name>Academician I.P. Pavlov First St. Petersburg State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.24884/1607-4181-2025-32-3-61-67</article-id><article-id custom-type="elpub" pub-id-type="custom">uzspbgmu-1136</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ РАБОТЫ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL PAPERS</subject></subj-group></article-categories><title-group><article-title>Структура заболеваемости и риск возникновения онкологической патологии у пациентов с хронической болезнью почек на примере популяции Санкт-Петербурга</article-title><trans-title-group xml:lang="en"><trans-title>The structure of morbidity and the risk of oncological pathology in patients with chronic kidney disease using the example of the population of Saint Petersburg</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5153-2061</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Палтышев</surname><given-names>И. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Paltyshev</surname><given-names>I. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Палтышев Илья Александрович, кандидат медицинских наук, врач-онколог онкологического отделения № 1, руководитель отделения детской хирургии НИИ хирургии и неотложной медицины, доцент кафедры онкологии ФПО</p><p>197022, Санкт-Петербург, ул. Льва Толстого, д. 6-8</p></bio><bio xml:lang="en"><p>Paltyshev Ilya A., Cand. of Sci. (Med), Oncologist of the Oncological Department № 1, Head of the Department of Pediatric Surgery, Research Institute of Surgery and Emergency Medicine, Associate Professor of the Department of Oncology of the Faculty of Postgraduate Education</p><p>6-8, L’va Tolstogo str., Saint Petersburg, 197022</p></bio><email xlink:type="simple">Eexss@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0830-3797</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Беляев</surname><given-names>М. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Belyaev</surname><given-names>M. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Беляев Михаил Алексеевич, кандидат медицинских наук, научный сотрудник, руководитель отделения абдоминальной онкологии, заместитель главного врача клиник по онкологии</p><p>197022, Санкт-Петербург, ул. Льва Толстого, д. 6-8</p></bio><bio xml:lang="en"><p>Belyaev Mikhail A., Cand. of Sci. (Med), Research Fellow, Head of the Department of Abdominal Oncology, Deputy Chief Physician of Oncology Clinics</p><p>6-8, L’va Tolstogo str., Saint Petersburg, 197022</p></bio><email xlink:type="simple">8628926@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7425-8202</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Вовин</surname><given-names>К. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Vovin</surname><given-names>K. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Вовин Кирилл Николаевич, кандидат медицинских наук, врач- онколог, хирург онкологического отделения № 1 НИИ хирургии и неотложной медицины, доцент кафедры онкологии ФПО</p><p>197022, Санкт-Петербург, ул. Льва Толстого, д. 6-8</p></bio><bio xml:lang="en"><p>Vovin Kirill N., Cand. of Sci. (Med), Oncologist, Surgeon of the Oncological Department № 1, Research Institute of Surgery and Emergency Medicine, Associate Professor of the Department of Oncology of the Faculty of Postgraduate Education</p><p>6-8, L’va Tolstogo str., Saint Petersburg, 197022</p></bio><email xlink:type="simple">vovinmd@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8514-5377</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Захаренко</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Zakharenko</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Захаренко Александр Анатольевич, доктор медицинских наук, профессор, зав. кафедрой онкологии ФПО</p><p>197022, Санкт-Петербург, ул. Льва Толстого, д. 6-8</p></bio><bio xml:lang="en"><p>Zakharenko Aleksandr A., Dr. of Sci. (Med), Professor, Head of the Department of Oncology of the Faculty of Postgraduate Education</p><p>6-8, L’va Tolstogo str., Saint Petersburg, 197022</p></bio><email xlink:type="simple">9516183@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6380-137X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Багненко</surname><given-names>С. Ф.</given-names></name><name name-style="western" xml:lang="en"><surname>Bagnenko</surname><given-names>S. F.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Багненко Сергей Фёдорович, доктор медицинских наук, профессор, академик РАН, ректор</p><p>197022, Санкт-Петербург, ул. Льва Толстого, д. 6-8</p></bio><bio xml:lang="en"><p>Bagnenko Sergey F., Dr. of Sci. (Med.), Professor, Academician of the Russian Academy of Sciences, Rector</p><p>6-8, L’va Tolstogo str., Saint Petersburg, 197022</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">Первый Санкт-Петербургский государственный медицинский университет имени академика И. П. Павлова<country>Россия</country></aff><aff xml:lang="en">Pavlov University<country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>16</day><month>12</month><year>2025</year></pub-date><volume>32</volume><issue>3</issue><fpage>61</fpage><lpage>67</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Палтышев И.А., Беляев М.А., Вовин К.Н., Захаренко А.А., Багненко С.Ф., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Палтышев И.А., Беляев М.А., Вовин К.Н., Захаренко А.А., Багненко С.Ф.</copyright-holder><copyright-holder xml:lang="en">Paltyshev I.A., Belyaev M.A., Vovin K.N., Zakharenko A.A., Bagnenko S.F.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.sci-notes.ru/jour/article/view/1136">https://www.sci-notes.ru/jour/article/view/1136</self-uri><abstract><sec><title>Введение</title><p>Введение. Онкологические больные с хронической болезнью почек 5 диализной стадии (ХБП 5д ст.) составляют отдельную, сложную группу пациентов. Проведение таким больным диагностики и специализированного онкологического лечения зачастую сопряжено с рядом трудностей и рисков. Однако до сих пор нет данных о частоте возникновения и преимущественной локализации злокачественных опухолей у пациентов с ХБП на российской популяции.</p><p>Цель – определить частоту выявления солидной онкопатологии у лиц с ХБП 5д ст. на примере популяции г. Санкт- Петербурга.</p></sec><sec><title>Методы и материалы</title><p>Методы и материалы. В 2019 г. население Санкт-Петербурга составило 5 328 890 человек. Число новых случаев солидных злокачественных новообразований заболеваний (ЗНО) в 2019 г. составило 20028 человек. Число пациентов, состоявших на 31.12.2018 г. в нефрологическом реестре Санкт-Петербурга было 2958 человек с ХБП 5д ст.</p></sec><sec><title>Результаты</title><p>Результаты. При сопоставлении баз с впервые выявленной онкопатологией в 2019 г. и базы учета нефрологических пациентов Санкт-Петербурга установлено, что солидные ЗНО диагностированы у 37 пациентов, страдавших ХБП 5д ст. Чаще всего локализациями ЗНО при ХБП 5д ст. были: рак легкого, желудка, предстательной железы, матки.</p></sec><sec><title>Выводы</title><p>Выводы. Риск развития солидной ЗНО при ХБП 5д ст. был значимо выше – отношение шансов (ОШ) составило 3,353.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Introduction</title><p>Introduction. Cancer patients with chronic kidney disease stage 5 on dialysis (CKD 5D) constitute a separate, complex group of patients. Conducting diagnostics and specialized oncological treatment for such patients is often associated with a number of difficulties and risks. However, there is still no data on the incidence and predominant localization of malignant tumors in patients with CKD in the Russian population.</p><p>The objective was to determine the frequency of detection of solid oncopathology in people with CKD 5D using the example of the population of St. Petersburg.</p></sec><sec><title>Methods and materials</title><p>Methods and materials. In 2019, the population of Saint Petersburg was 532,890 people. The number of new cases of solid malignant neoplasms (MNP) of diseases in 2019 amounted to 20,028 people. The number of patients registered on 31.12.2018 in the nephrological registry of Saint Petersburg was 2,958 people with CKD 5D.</p></sec><sec><title>Results</title><p>Results. When comparing the databases with the first oncopathology in 2019 and the database of nephrological patients in Saint Petersburg, it was revealed that solid MNP were diagnosed in 37 patients suffering from CKD 5D. Most often, the localization of solid MNP with CKD 5D patients were: lung, stomach, prostate, and uterine cancers.</p></sec><sec><title>Conclusions</title><p>Conclusions. The risk of developing solid MNP in patients with ESRD was significantly higher – the odds ratio (OR) was 3.353.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>хроническая болезнь почек</kwd><kwd>гемодиализ</kwd><kwd>заболеваемость</kwd><kwd>канцерогенез</kwd><kwd>рак желудка</kwd><kwd>рак яичников</kwd></kwd-group><kwd-group xml:lang="en"><kwd>chronic kidney disease</kwd><kwd>hemodialysis</kwd><kwd>morbidity</kwd><kwd>carcinogenesis</kwd><kwd>gastric cancer</kwd><kwd>ovarian cancer</kwd></kwd-group><funding-group xml:lang="ru"><funding-statement>Авторы выражают благодарность в редактировании текста и консультативной работе с материалом начальнику отдела медицинской статистики опухолевых заболеваний СПб ГБУЗ МИАЦ – Хиже Валентину Васильевичу и Земченкову Александру Юрьевичу, главному внештатному специалисту – нефрологу Санкт- Петербурга в 2019 г.</funding-statement></funding-group><funding-group xml:lang="en"><funding-statement>The authors express their gratitude in the text editing and advisory work with the material to the Head of the Department of Medical Statistics of Tumor Diseases of the Saint Petersburg State Budgetary Healthcare Institution “Medical Information and Analytical Center” – Khizhe Valentin Vasilievich and Zemchenkov Aleksandr Iurievich – the Chief Freelance Specialist-Nephrologist of Saint Petersburg in 2019.</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Bray, F., Ferlay, J., Soerjomataram, I., et al. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians, 68(6), 394–424. https://doi.org/10.3322/caac.21492.).</mixed-citation><mixed-citation xml:lang="en">Bray, F., Ferlay, J., Soerjomataram, I., et al. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians, 68(6), 394–424. https://doi.org/10.3322/caac.21492.).</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Шахзадова А.О., Старинский В.В., Лисичникова И.В. Состояние онкологической помощи населению России в 2022 году. Сибирский онкологический журнал. 2023; 22(5): 5–13. – doi: 10.21294/1814-4861-2023-22-5-5-13.</mixed-citation><mixed-citation xml:lang="en">Shakhzadova A.O., Starinsky V.V., Lisichnikova I.V. Cancer care to the population of Russia in 2022. Siberian journal of oncology. 2023;22(5):5-13. (In Russ.) https://doi.org/10.21294/1814-4861-2023-22-5-5-13 (In Rus).</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Lv JC, Zhang LX. Prevalence and Disease Burden of Chronic Kidney Disease. Adv Exp Med Biol. 2019; 1165:3-15. doi: 10.1007/978-981-13-8871-2_1. PMID: 31399958.</mixed-citation><mixed-citation xml:lang="en">Lv JC, Zhang LX. Prevalence and Disease Burden of Chronic Kidney Disease. Adv Exp Med Biol. 2019; 1165:3-15. doi: 10.1007/978-981-13-8871-2_1. PMID: 31399958.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Румянцева Е.И. Хроническая болезнь почек как глобальная проблема для общественного здоровья: динамика заболеваемости и смертности. Проблемы стандартизации в здравоохранении. 2021.</mixed-citation><mixed-citation xml:lang="en">Rumyantseva EI. Chronic kidney disease as a global public health problem: trends in morbidity and mortality. Health Care Standardization Problems. 2021; 1-2: 41-49. DOI: 10.26347/1607-2502202101-02041-049(In Rus).</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Hu, M.; Wang, Q.; Liu, B.; Ma, Q.; Zhang, T.; Huang, T.; Lv, Z.; Wang, R. Chronic Kidney Disease and Cancer: Inter-Relationships and Mechanisms. Front. Cell Dev. Biol. 2022, 10, 868715.</mixed-citation><mixed-citation xml:lang="en">Hu, M.; Wang, Q.; Liu, B.; Ma, Q.; Zhang, T.; Huang, T.; Lv, Z.; Wang, R. Chronic Kidney Disease and Cancer: Inter-Relationships and Mechanisms. Front. Cell Dev. Biol. 2022, 10, 868715.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Ciorcan, M.; Chisavu, L.; Mihaescu, A.; Gadalean, F.; Bob, F.R.; Negru, S.; Schiller, O.M.; Grosu, I.D.; Marc, L.; Chisavu, F.; et al. chronic kidney disease in cancer patients, the analysis of a large oncology database from Eastern Europe. PLoS ONE 2022, 17, e0265930.</mixed-citation><mixed-citation xml:lang="en">Ciorcan, M.; Chisavu, L.; Mihaescu, A.; Gadalean, F.; Bob, F.R.; Negru, S.; Schiller, O.M.; Grosu, I.D.; Marc, L.; Chisavu, F.; et al. chronic kidney disease in cancer patients, the analysis of a large oncology database from Eastern Europe. PLoS ONE 2022, 17, e0265930.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Plaisier, E.; Ronco, P. Screening for Cancer in Patients with Glomerular Diseases. Clin. J. Am. Soc. Nephrol. 2020, 15, 886–888.</mixed-citation><mixed-citation xml:lang="en">Plaisier, E.; Ronco, P. Screening for Cancer in Patients with Glomerular Diseases. Clin. J. Am. Soc. Nephrol. 2020, 15, 886–888.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Yarandi N, Shirali AC. Onconephrology: Core Curriculum 2023. Am J Kidney Dis. 2023 Dec;82(6):743-761. doi: 10.1053/j.ajkd.2023.04.014. Epub 2023 Oct 17. PMID: 37855786.</mixed-citation><mixed-citation xml:lang="en">Yarandi N, Shirali AC. Onconephrology: Core Curriculum 2023. Am J Kidney Dis. 2023 Dec;82(6):743-761. doi: 10.1053/j.ajkd.2023.04.014. Epub 2023 Oct 17. PMID: 37855786.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Lees JS, Elyan BMP, Herrmann SM, Lang NN, Jones RJ, Mark PB. The 'other' big complication: how chronic kidney disease impacts on cancer risks and outcomes. Nephrol Dial Transplant. 2023 May 4;38(5):1071-1079. doi: 10.1093/ndt/gfac011. PMID: 35090037; PMCID: PMC10157781.</mixed-citation><mixed-citation xml:lang="en">Lees JS, Elyan BMP, Herrmann SM, Lang NN, Jones RJ, Mark PB. The 'other' big complication: how chronic kidney disease impacts on cancer risks and outcomes. Nephrol Dial Transplant. 2023 May 4;38(5):1071-1079. doi: 10.1093/ndt/gfac011. PMID: 35090037; PMCID: PMC10157781.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Matas AJ, Simmons RL, Kjellstrand CM, Buselmeier TJ, Najarian JS. Increased incidence of malignancy during chronic renal failure. Lancet. 1975 Apr 19;1(7912):883-6. doi: 10.1016/s0140-6736(75)91684-0. PMID: 47534.</mixed-citation><mixed-citation xml:lang="en">Matas AJ, Simmons RL, Kjellstrand CM, Buselmeier TJ, Najarian JS. Increased incidence of malignancy during chronic renal failure. Lancet. 1975 Apr 19;1(7912):883-6. doi: 10.1016/s0140-6736(75)91684-0. PMID: 47534.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Janus, N., Launay-Vacher, V., Thyss, A., et al. (2013). Management of anticancer treatment in patients under chronic dialysis: results of the multicentric CANDY (CANcer and DialYsis) study. Annals of oncology: official journal of the European Society for Medical Oncology, 24(2), 501–507. https://doi.org/10.1093/annonc/mds344.</mixed-citation><mixed-citation xml:lang="en">Janus, N., Launay-Vacher, V., Thyss, A., et al. (2013). Management of anticancer treatment in patients under chronic dialysis: results of the multicentric CANDY (CANcer and DialYsis) study. Annals of oncology: official journal of the European Society for Medical Oncology, 24(2), 501–507. https://doi.org/10.1093/annonc/mds344.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Lee, J. E., Han, S. H., Cho, B. C., et al. (2009). Cancer in patients on chronic dialysis in Korea. Journal of Korean medical science, 24 Suppl (Suppl 1), S95–S101. https://doi.org/10.3346/jkms.2009.24.S1.S95.</mixed-citation><mixed-citation xml:lang="en">Lee, J. E., Han, S. H., Cho, B. C., et al. (2009). Cancer in patients on chronic dialysis in Korea. Journal of Korean medical science, 24 Suppl (Suppl 1), S95–S101. https://doi.org/10.3346/jkms.2009.24.S1.S95.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Park, S., Lee, S., Kim, Y., et al. (2019). Risk of cancer in pre-dialysis chronic kidney disease: A nationwide population-based study with a matched control group. Kidney research and clinical practice, 38(1), 60–70. https://doi.org/10.23876/j.krcp.18.0131.</mixed-citation><mixed-citation xml:lang="en">Park, S., Lee, S., Kim, Y., et al. (2019). Risk of cancer in pre-dialysis chronic kidney disease: A nationwide population-based study with a matched control group. Kidney research and clinical practice, 38(1), 60–70. https://doi.org/10.23876/j.krcp.18.0131.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Oh, H. J., Lee, H. A., Moon, C. et al. (2020). The Combined Impact of Chronic Kidney Disease and Diabetes on the Risk of Colorectal Cancer Depends on Sex: A Nationwide Population-Based Study. Yonsei medical journal, 61(6), 506–514. https://doi.org/10.3349/ymj.2020.61.6.506.</mixed-citation><mixed-citation xml:lang="en">Oh, H. J., Lee, H. A., Moon, C. et al. (2020). The Combined Impact of Chronic Kidney Disease and Diabetes on the Risk of Colorectal Cancer Depends on Sex: A Nationwide Population-Based Study. Yonsei medical journal, 61(6), 506–514. https://doi.org/10.3349/ymj.2020.61.6.506.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Oh HJ, Lee HA, Moon CM, Ryu DR. Incidence risk of various types of digestive cancers in patients with pre-dialytic chronic kidney disease: A nationwide population-based cohort study. PLoS One. 2018 Nov 20;13(11):e0207756. doi: 10.1371/journal.pone.0207756. PMID: 30458033; PMCID: PMC6245741.</mixed-citation><mixed-citation xml:lang="en">Oh HJ, Lee HA, Moon CM, Ryu DR. Incidence risk of various types of digestive cancers in patients with pre-dialytic chronic kidney disease: A nationwide population-based cohort study. PLoS One. 2018 Nov 20;13(11):e0207756. doi: 10.1371/journal.pone.0207756. PMID: 30458033; PMCID: PMC6245741.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Lee YC, Hung SY, Wang HK, Lin CW, Wang HH, Chang MY, Sung JM, Chiou YY, Lin SH. Is there different risk of cancer among end-stage renal disease patients undergoing hemodialysis and peritoneal dialysis? Cancer Med. 2018 Feb;7(2):485-498. doi: 10.1002/cam4.1289. Epub 2018 Jan 22. PMID: 29356425; PMCID: PMC5806101.</mixed-citation><mixed-citation xml:lang="en">Lee YC, Hung SY, Wang HK, Lin CW, Wang HH, Chang MY, Sung JM, Chiou YY, Lin SH. Is there different risk of cancer among end-stage renal disease patients undergoing hemodialysis and peritoneal dialysis? Cancer Med. 2018 Feb;7(2):485-498. doi: 10.1002/cam4.1289. Epub 2018 Jan 22. PMID: 29356425; PMCID: PMC5806101.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Супрунович К.С., Палтышев И.А., Захаренко А.А. и др. Онконефрология: острая болезнь почек после превентивной илеостомии у пациента с колоректальным раком. Нефрология. 2023;27(1):102-107. https://doi.org/10.36485/1561-6274-2023-27-1-102-107..</mixed-citation><mixed-citation xml:lang="en">Suprunovich K.S., Paltyshev I.A., Zakharenko A.A., et al. Onconephrology: acute kidney disease after preventive ileostomy in a patient with colorectal cancer. Nephrology (Saint-Petersburg). 2023;27(1):102-107. (In Russ.) https://doi.org/10.36485/1561-6274-2023-27-1-102-107(In Rus).</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Есаян А.М., Аль-Шукри С., Мосоян М.С. Почечно-клеточный рак и хроническая болезнь почек: внимание к отдаленным неонкологическим исходам. Нефрология. 2012; 16(4):94-99. https://doi.org/10.24884/1561-6274-2012-16-4-94-99.</mixed-citation><mixed-citation xml:lang="en">Yesayan A.M., Al-Shukri S., Mosoyan M.S. Renal cell carcinoma and chronic kidney disease: attention to distant non-oncologic results. Nephrology (Saint-Petersburg). 2012;16(4):94-99. (In Russ.) https://doi.org/10.24884/1561-6274-2012-16-4-94-99 (In Rus).</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Коваленко Н.В., Иванов А.И., Галеев Ш.Р. и др. Хирургическое лечение злокачественной опухоли желудка у пациента с хронической болезнью почек на программном гемодиализе. Креативная хирургия и онкология. 2021;11(4):337-342. https://doi.org/10.24060/2076-3093-2021-11-4-337-342.</mixed-citation><mixed-citation xml:lang="en">Kovalenko N.V., Ivanov A.I., Galeev S.R. et al. Surgical Treatment of Gastric Malignancy in Chronic Kidney Disease Patient with Long-Term Haemodialysis. Creative surgery and oncology. 2021;11(4):337-342. (In Russ.) https://doi.org/10.24060/2076-3093-2021-11-4-337-342(In Rus).</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
